bFGF and tumor angiogenesis — Back in the limelight? (original) (raw)

• Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
  Article CAS PubMed Google Scholar
• Kerbel, R.S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays 13, 31–36 (1991).
  Article CAS PubMed Google Scholar
• Czubayko, F. et al. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Med. 3, 1137–1140 (1997).
  Article CAS PubMed Google Scholar
• Risau, W. What, if anything, is an angiogenic factor?. Cancer Metastasis Rev. 15, 149–151 (1996).
  Article CAS PubMed Google Scholar
• Wu, D.Q. et al. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266, 16778–16785 (1991).
  CAS PubMed Google Scholar
• Czubayko, F., Smith, R.V., Chung, H.C. & Wellstein, A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem. 269, 28243–28248 (1994).
  CAS PubMed Google Scholar
• Friesel, R.E. & Maciag, T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919–925 (1995).
  Article CAS PubMed Google Scholar
• Kandel, J. et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095–1104 (1991).
  Article CAS PubMed Google Scholar
• Cheng, S.Y. et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. U.S.A. 93, 8502–8507 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Rak, J. et al. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14, 263–277 (1995).
  Article CAS PubMed Google Scholar
• Bouck, N., Stellmach, V. & Hsu, S.C. How tumors become angiogenic. Adv. Cancer Res. 69, 135–174 (1996).
  Article CAS PubMed Google Scholar
• Stavri, G.T. et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle Cells. Circulation 92, 11–14 (1995).
  Article CAS PubMed Google Scholar
• Goto, F., Goto, K. & Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial Cells within collagen gels. Lab. Invest. 69, 508–517 (1993).
  CAS PubMed Google Scholar
• Asahara, T. et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, 365–371 (1995).
  Article CAS Google Scholar
• Millauer, B. et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615–1620 (1996).
  CAS PubMed Google Scholar
• Warren, R.S. et al. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789–1797 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U.S.A. 93, 14765–14770 (1996).
  Article CAS PubMed PubMed Central Google Scholar